Clinical Trials Using Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes

Clinical trials are research studies that involve people. The clinical trials on this list are studying Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Donor T Cell Therapy in Treating Immunocompromised Patients with Adenovirus-Related Disease

    This phase I trial studies the side effects of allogeneic adenovirus-specific cytotoxic T lymphocytes (donor T cell therapy) and to see how well they work in treating patients with a weakened immune system (immunocompromised) and adenovirus-related disease. Allogeneic adenovirus-specific cytotoxic T lymphocytes are made from donated blood cells grown in the laboratory and are designed to kill viruses that can cause infections in immunocompromised patients with adenovirus-related disease.
    Location: M D Anderson Cancer Center, Houston, Texas